Ipamorelin (10mg)

Ipamorelin (10mg)

$74.99
$74.99
SAVE Sold out

✔ Verified 99+% Purity

✔ Third-Party Approved & Tested

✔ Fast Australian Shipping

Research Use Only

This product is sold for research purposes only. It is not intended for human or animal consumption. By purchasing this product, you confirm that you are a qualified researcher or are purchasing for legitimate research purposes.

Bacteriostatic Water (20mg)
Add Bacteriostatic Water (20mg)
Required for reconstitution
$24.99
Ipamorelin (10mg)

Ipamorelin (10mg)

$74.99
$74.99
SAVE Sold out

Shipping Information

Orders are processed and dispatched within 24 hours of payment confirmation (Monday–Friday). Delivery typically arrives within 1–4 business days via Standard post, and 1-2 business days via Express post.

View full details

Ipamorelin

Supplied as a lyophilized (freeze-dried) white powder in a sealed sterile vial. Requires reconstitution with bacteriostatic water prior to use. Each vial contains 10mg of Ipamorelin at ≥99% purity.

Ipamorelin is one of the most selective growth hormone secretagogues studied and a potent agonist of the ghrelin/growth hormone secretagogue receptor (GHS-R1a). Its modified pentapeptide sequence (Aib-His-D-2-Nal-D-Phe-Lys-NH₂) contributes to its exceptional selectivity and stability. It has been extensively researched across a number of settings and is known to improve bone density, boost muscle repair and development, support IGF-1 axis signalling, and promote selective GH release with minimal impact on cortisol and prolactin compared to earlier generation secretagogues.

Research Background

Research has characterised Ipamorelin as one of the most selective GHS-R1a agonists available, with studies comparing its pharmacology to other growth hormone secretagogues including GHRP-6, GHRP-2, and hexarelin. These studies indicate that Ipamorelin demonstrates dose-dependent GH release with a more favourable selectivity profile than earlier generation compounds. The peptide has also been studied across the GH/IGF-1 axis, including investigations into pulsatile versus continuous GH release patterns and its potential interactions with GHRH analogues in combined research protocols.

Key Research Areas
GH secretion and GHS-R1a receptor signalling
IGF-1 axis and downstream growth factor signalling
Bone density and skeletal tissue models
Muscle repair, development, and recovery studies
Bowel motility and gastric function research
Pulsatile vs continuous GH release pattern studies
Studied Mechanisms
Selective GHS-R1a agonism with minimal off-target effects
Dose-dependent GH release stimulation
Minimal cortisol and prolactin interference
Insulin release stimulation from pancreatic models
Synergistic GH response when combined with GHRH analogues

Product Specifications

Molecular FormulaC₃₈H₄₉N₉O₅
Molecular Weight711.9 g/mol
SequenceAib-His-D-2-Nal-D-Phe-Lys-NH₂
AppearanceLyophilized Powder
Purity≥99% (HPLC Verified)
StorageStore at -20°C, away from light and moisture
Research Use Only

This product is strictly intended for in vitro laboratory research purposes only. It is not approved for human or veterinary use, and is not intended for consumption, injection, or any therapeutic application.